Cargando…
Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL‐24 enhances the antitumor effect of temozolomide against melanoma
BACKGROUND: Temozolomide (TMZ) is widely used to treat melanoma; however, response rates to TMZ are low because of rapid and frequent resistance. Conditionally, replicative adenoviruses (CRAds) are an effective and promising approach. The receptor for adenovirus is coxsackie‐adenovirus receptor (CAR...
Autores principales: | Yang, Ming, Yang, Chunsheng, Tao, Yingkai, Tang, Jianqin, Huang, Qian, Guo, Wenwen, Feng, Shouxin, Jiang, Aijun, Xu, Xifeng, Jiang, Guan, Liu, Yanqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308089/ https://www.ncbi.nlm.nih.gov/pubmed/30406970 http://dx.doi.org/10.1002/cam4.1843 |
Ejemplares similares
-
Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity
por: Flickinger Jr, John C, et al.
Publicado: (2020) -
Mobile phone use and glioma risk: A systematic review and meta-analysis
por: Yang, Ming, et al.
Publicado: (2017) -
A conditionally replicating adenovirus expressing IL-24 acts synergistically with temozolomide to enhance apoptosis in melanoma cells in vitro
por: Liang, Zhen, et al.
Publicado: (2017) -
Interleukin-24 enhancing antitumor activity of chimeric oncolytic adenovirus for treating acute promyelocytic leukemia cell
por: Liu, Li, et al.
Publicado: (2019) -
Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
por: Pang, Yanyu, et al.
Publicado: (2018)